2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO27] Mini-Oral Session 27　Head and Neck Cancer 2（Clinical Practice）
【E】

Fri. Feb 18, 2022 2:05 PM - 2:55 PM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Yoshinori Imamura（Department of Medical Oncology and Hematology, Kobe University Hospital），Susumu Okano（Department of Head and Neck Medical Oncology, National Cancer Center Hospital East）

[MO27-6] When should we start sorafenib or lenvatinib for radioactive iodine-refractory differentiated thyroid carcinoma?

○Yasuhiro Ito1,2, Onoda Naoyoshi2, Akira Miyauchi2 (1.Department of Clinical Trial, Kuma Hospital, 2.Department of Surgery, Kuma Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password